Cargando…
A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report
BACKGROUND: In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mutations. Most BRCA alterations in pancreatic cancer are frame-s...
Autores principales: | Wang, Deqiang, Guan, Ruting, Tao, Qing, Liu, Sisi, Yu, Man, Li, Xiaoqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788890/ https://www.ncbi.nlm.nih.gov/pubmed/33407459 http://dx.doi.org/10.1186/s12920-020-00850-6 |
Ejemplares similares
-
Olaparib and somatic BRCA mutations
por: George, Angela, et al.
Publicado: (2017) -
Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma
por: Grzelak, Doreen
Publicado: (2021) -
Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer
por: Ghareyazi, Amin, et al.
Publicado: (2021) -
Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation
por: Schwartzberg, Lee S., et al.
Publicado: (2021) -
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
por: Paradiso, Angelo Virgilio, et al.
Publicado: (2020)